The RECORD Asia-Pacific Atrial Fibrillation Registry (RECORDAF-AP)
REgistry on Cardiac Rhythm disORDers in Asia-Pacific
The Primary objective of this registry is to assess the control of Atrial Fibrillation (AF) over one year in patients attending clinical or specialized practices.
The Secondary objectives are:
- To describe key demographics and treatment features in AF patients visiting cardiologists in various countries in Asia-Pacific.
- To establish correlation between control of AF and clinical outcomes.
- To establish correlation between treatment strategies and AF control.
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Macquarie Park, Australia
- Sanofi-Aventis Administrative Office
-
-
-
-
-
Shanghai, China
- Sanofi-Aventis Administrative Office
-
-
-
-
-
Hong Kong, Hong Kong
- Sanofi-Aventis Administrative Office
-
-
-
-
-
Seoul, Korea, Republic of
- Sanofi-Aventis Administrative Office
-
-
-
-
-
Kuala Lumpur, Malaysia
- Sanofi-Aventis Administrative Office
-
-
-
-
-
Makati City, Philippines
- Sanofi-Aventis Administrative Office
-
-
-
-
-
Taipei, Taiwan
- Sanofi-Aventis Administrative Office
-
-
-
-
-
Bangkok, Thailand
- Sanofi-Aventis Administrative Office
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Patient presenting with either:
- History of atrial fibrillation diagnosed < 1 year by standard Electro-Cardiogram (ECG) or by ECG-Holter monitoring (treated or not or whatever rhythm at inclusion).
- New atrial fibrillation diagnosed by standard ECG or by ECG-Holter monitoring at inclusion visit.
- Patient eligible for a pharmacological treatment of AF (by rhythm or rate control agent).
Exclusion Criteria:
- AF due to transient cause (thyrotoxicosis, alcohol intoxication, acute phase of myocardial infarction, pericarditis, myocarditis, electrocution, pulmonary embolism or other pulmonary disease, hydroelectrolytic disorder, metabolic disorder, etc.).
- Post cardiac surgery AF (≤3 months).
- Mentally disabled patients unable to understand or sign the written informed consent.
- Patients unable to comply with follow-up visits.
- Patients with pacemaker, Implantable Cardioverter Defibrillator (ICD).
- Patients scheduled for pulmonary vein ablation, AV node/His bundle ablation, or pacemaker implantation.
- Patient included in any clinical trial in the previous 3 months.
- Pregnant or breastfeeding women.
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Rate of therapeutic success by patients in sinus rhythm or heart rate control at target (< 80 beats per minute at rest)
Time Frame: At 12 ± 3 months follow-up
|
At 12 ± 3 months follow-up
|
|
Comparison of clinical outcomes (Cardiovascular death, Stroke, Myocardial infarction, etc) for patients in rhythm versus rate control strategies
Time Frame: At 12 ± 3 months follow-up
|
At 12 ± 3 months follow-up
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Treatment effectiveness evaluated by the proportion of patients in sinus rhythm
Time Frame: At 1 year follow-up
|
At 1 year follow-up
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- DIREG_R_04434
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.